Health News Archive - June 10, 2009
Three-of-Four Patients Surveyed Experience Daily Pain From Rheumatoid Arthritis Despite Current Treatment; Findings Unveiled at the European League Against Rheumatism Annual Congress of Rheumatology COPENHAGEN, Denmark, June 10 /PRNewswire-FirstCall/ -- Results from the Rheumatoid Arthritis: Insights, Strategies & Expectations (RAISE) survey of more than 500 rheumatoid arthritis (RA) patients throughout Europe and Canada revealed a majority of patients still suffer from pain (79 percent), fatigue (67 percent) and joint stiffness (57 percent) on a regular basis despite current treatment, while more than half (51 percent) of RA patients feel their disease controls their life.
Alzheimer's disease may be associated with an increased risk of death among both white and African-American older adults, U.S. researchers said.
SEATTLE, June 10 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
The International Conference on Concussion in Sports says children and teens require different treatment for concussions than adults, a U.S.
HUNTINGTON BEACH, Calif., June 10 /PRNewswire-FirstCall/ -- Forterus Inc. (Pink Sheets: FTER), which, through its ABTTC Inc.
GLEN ROCK, N.J., June 10 /PRNewswire/ -- Fingertip Formulary(R), the leading provider of access to and insight into U.S. formulary data, introduces a free, customized mobile solution, specifically designed for the iPhone.
First-In-Class Human Collagen Technology Used in Cranial Surgical Procedures EATONTOWN, N.J., June 10 /PRNewswire-FirstCall/ -- Osteotech, Inc.
- Paragraph IV Litigation Underway - CORONA, Calif., June 10 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.
New Capabilities Will Further Extend GeneXpert System Technology Advantages SUNNYVALE, Calif., June 10 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced that it has received a notice of grant award from the National Institute of Allergy and Infectious Diseases to develop new ten-color detection technology for use in its GeneXpert(R) System.
JERUSALEM, June 10 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral delivery systems, announced that Oramed was chosen to present at the 8th National Life Science & Technology Week ILSI-BIOMED Conference, Israel 2009.